Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

63.64
-0.1100-0.17%
Post-market: 63.660.0195+0.03%19:55 EDT
Volume:7.06M
Turnover:448.25M
Market Cap:129.56B
PE:14.01
High:64.20
Open:64.15
Low:63.27
Close:63.75
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:1.05
T/O Rate:0.35%
Dividend:2.51
Dividend Rate:3.95%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:5.80
PE(LYR):18.39

Loading ...

Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial

TIPRANKS
·
Sep 08

Bristol Myers Squibb's Therapy Meets Mid-Stage Trial Goal

Reuters
·
Sep 08

Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 Quintessential Trial of the Potential First-in-Class Gprc5d-Directed Car T Cell Therapy, Arlocabtagene Autoleucel ...

THOMSON REUTERS
·
Sep 08

Bristol-Myers Squibb Company - Phase 2 Trial Met Primary Endpoint of Overall Response Rate and Complete Response Rate

THOMSON REUTERS
·
Sep 08

Bristol-Myers Squibb Company - Arlo-Cel Safety Profile Consistent with Other Car T Cell Therapies

THOMSON REUTERS
·
Sep 08

Jeito Capital Promotes Pascal Touchon to Partner

Reuters
·
Sep 08

Berenberg Bank Sticks to Its Buy Rating for Bloomsbury Publishing (BMY)

TIPRANKS
·
Sep 08

Bristol Myers Squibb Co. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Bristol-Myers Squibb Moves Into Depression Market With New Phase 2 Trial

TIPRANKS
·
Sep 05

Drugmakers Halt Autoimmune Trials After Deaths, Life-Threatening Side Effects

Dow Jones
·
Sep 04

Market Chatter: Bristol Myers Squibb Paused Zola-Cel Trials Over Safety Concerns

MT Newswires Live
·
Sep 04

Dow Jones Top Company Headlines at 11 PM ET: the 'Deeply Nerdy' Founders Behind Nvidia's $13 Billion Bet on Hugging Face | Musk's ...

Dow Jones
·
Sep 04

Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer

Reuters
·
Sep 03

Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services

Dow Jones
·
Sep 03

Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 03

London Midcaps Lead Losses as Rising Gilt Yields Weigh; Reckitt Gains

Reuters
·
Sep 02

U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions

Reuters
·
Sep 01

Oxford BioMedica Slides as Novartis, Bristol-Myers Squibb Pause CAR-T Autoimmune Trials

Reuters
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Bristol-Myers Squibb Spokesperson - Implemented a Voluntary Pause to Review Clinical Data Across Our Zola-Cel Program

THOMSON REUTERS
·
Sep 01